RIM
BIIB icon

Rampart Investment Management’s Biogen BIIB Stock Holding History

Rampart Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-951
Closed -$270K – 46
2020
Q3 		$270K Sell
951
-2,728
-74% -$761K 0.17% 136
2020
Q2 		$984K Buy
3,679
+1,034
+39% +$311K 0.17% 168
2020
Q1 		$837K Buy
2,645
+498
+23% +$151K 0.4% 58
2019
Q4 		$637K Sell
2,147
-18
-0.8% -$4.99K 0.08% 274
2019
Q3 		$504K Sell
2,165
-110
-5% -$25.6K 0.06% 304
2019
Q2 		$532K Sell
2,275
-164
-7% -$37.9K 0.06% 306
2019
Q1 		$577K Buy
2,439
+299
+14% +$94.2K 0.07% 295
2018
Q4 		$644K Sell
2,140
-2,085
-49% -$665K 0.18% 126
2018
Q3 		$828K Sell
4,225
-661
-14% -$228K 0.36% 66
2018
Q2 		$1.42M Sell
4,886
-829
-15% -$233K 0.14% 210
2018
Q1 		$1.56M Buy
5,715
+3,124
+121% +$970K 0.15% 191
2017
Q4 		$825K Sell
2,591
-345
-12% -$111K 0.32% 77
2017
Q3 		$919K Buy
2,936
+131
+5% +$38.8K 0.31% 75
2017
Q2 		$761K Buy
2,805
+2,213
+374% +$585K 0.27% 83
2017
Q1 		$162K Buy
+592
New +$167K 0.06% 94

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rampart Investment Management's BIIB Position: Q4 2020 in Review

Rampart Investment Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 951 shares — an estimated $270K sold.

Rampart Investment Management first reported a position in BIIB in Q1 2017 and held it in 15 quarters. The position peaked at $1.56M in Q1 2018. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Rampart Investment Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 951 Biogen shares in Q4 2020, an estimated $270K.
  • Rampart Investment Management first reported a position in Biogen in Q1 2017 and held it in 15 quarters.
  • Rampart Investment Management's Biogen position peaked at $1.56M in Q1 2018.
  • 1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.